ArticleJournal of the European Academy of Dermatology and Venereology : JEADV2021

Real-world effectiveness of adalimumab in patients with moderate-to-severe hidradenitis suppurativa: the 1-year SOLACE study.

W Gulliver et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.